• Journal of Korea Technical Association of The Pulp and Paper Industry
• /
• v.46 no.6
• /
• pp.26-33
• /
• 2014

Frankincense resin was applied to Hanji to improve its physical properties. The resin-treated paper showed the increasement of physical properties such as weight, thickness, and density. The highest increasement in weight and density of resin-treated paper were found at 30% treatment concentrations and the largest values of density were $41g/m^2$ Hanji. With the increasement of concentration, the brightness was decreased and transparency was improved. Of the mechanical properties of the paper, the tensile index and burst index showed the improved values. The tear index, however, was decreased. The frankincense resin showed the highest result in the tensile index of resin-treated paper and the basis weight of $41g/m^2$ Hanji. The air resistance of the resin-treated paper got improved with the increase of the concentration and $105g/m^2$ Hanji showed the highest values. The highest improvement in air resistance may make the resin-treated Hanji possible to use for semipermeable materials.

• Microbiology and Biotechnology Letters
• /
• v.36 no.4
• /
• pp.343-352
• /
• 2008

Frankincense, the gum resin derived from Boswellia species, is complex mixtures composed of about $5{\sim}9%$ highly aromatic essential oil, $65{\sim}85%$ alcohol-soluble resins, and the remaining water-soluble gums. The anti-inflammatory properties of frankincense, alcohole-soluble resins, are well-recognized, but the question of whether aromatic essential oil also plays a role in the allergic asthma remains unanswered. This study was performed to evaluate anti-inflammatory effects of Boswellia sacra essential oil (BSEO) on ovalbumin (OVA)-induced asthma mouse model. BALB/c mice after intraperitoneal OVA sensitization were challenged with intratracheal OVA. One experimental group was inhaled with 0.3% BSEO for the later 8 weeks. BALB/c mice were sensitized and challenged with OVA and developed airway eosinophilia, mucus hypersecretion, and airway hyperresponsiveness. In contrast, the BSEO treated mice had reduced a number of eosinophils among BALF cells, goblet cell hyperplasia, and airway hyperresponsiveness. Cytokine analysis of BALF revealed that BSEO caused an increase in Th1 cytokine (interferon-$\gamma$ (IFN-$\gamma$)) and a decrease in Th2 cytokines (interleukin-4 (IL-4), IL-5 and IL-13) levels. In addition, the OVA-specific serum IgE and eotaxin levels were also reduced. In mice inhaled BSEO, $CD4^+$, $CD3^+/CCR3^+$, and $B220^+/CD23^+$ mediastinal lymph nodes cells were also decreased. These results suggest that inhaled BSEO as a immunomodulator in Th1/Th2 mediated asthma may have therapeutic potential for the treatment in allergic airway inflammation by a simple, cost-effective way.